Compugen Ltd., a clinical-stage cancer immunotherapy company using AI for drug discovery, announced its management will participate in a fireside chat at the H.C. Wainwright AI Based Drug Discovery & Development Conference on October 8, 2026. The event will be held virtually, with a live webcast available on Compugen's website. Compugen is advancing several cancer immunotherapy candidates, including COM701 for ovarian cancer and rilvegostomig, developed with AstraZeneca, currently in multiple clinical trials. This presentation highlights Compugen's innovative AI-driven approach and ongoing clinical progress in immuno-oncology.
Compugen's upcoming participation in an AI drug discovery conference is noted here with Pluang's Health sector market data as of Oct 06, 2026 17:51 WIB. Of 100 priced Health-sector US stocks tradable on Pluang, 67 rose and 25 fell today. Notable movers include BNGO at USD 1.50 with a 3.81% increase and a typical hold time of 49 days, NUWE at USD 0.72 up 3.72% with 76% buy order activity, and FLNA at USD 0.90 rising 3.45% with 92% buy order activity.
GM's third-quarter sales fell 5.5%, mainly due to a sharp drop in electric vehicle sales after a tax credit rush in 2025. Excluding EVs, sales slightly increased, showing GM is not deliberately limiting supply but focusing on pricing discipline. The ...
Nvidia's stock has grown dramatically over the past decade, turning a $10,000 investment into over $1.3 million. However, with a current market cap of $5.57 trillion, such exponential growth is unlikely to repeat. Analysts predict a 17.5% price incre...
A Santa Fe judge will soon decide how much Meta owes New Mexico after a jury found Meta liable for over 43 million data privacy violations related to the Cambridge Analytica scandal. The New Mexico Department of Justice demands between $35 billion an...
Over the past six months, Costco's stock has fallen by 10%, contrasting with the S&P 500's 17% gain. This decline has sparked debate on whether Costco's shares, now trading under $900, represent a buying opportunity. Investors are weighing if the pri...
The article explains a preference for the Vanguard S&P 500 ETF (VOO) over the Invesco QQQ Trust (QQQ) for long-term investing due to VOO's stability and quality filter. VOO excludes unprofitable and speculative firms, reducing risk compared to QQQ, w...
